This bill formally establishes and strengthens the Advisory Committee on Immunization Practices (ACIP), a group of medical experts who recommend which vaccines Americans should receive. Think of them as the official advisors to the government on vaccine policy.

Here's what the bill does: It requires the ACIP to review all new vaccines and make recommendations based on the best scientific evidence. When the CDC director receives these recommendations, they must either adopt them or publicly explain why they're rejecting them—and they have to notify Congress within 48 hours if they disagree. This creates transparency and accountability. The bill also specifies that the committee must meet at least three times a year and review new vaccines within 90 days of their approval. The committee will have 15-19 voting members selected from experts in fields like infectious diseases, epidemiology, and immunology, plus six non-voting representatives from major health agencies.

The practical impact is that vaccine recommendations will be based on solid science and made through a formal, documented process that Congress can oversee. The bill also requires that any changes to the Vaccine Injury Table (which lists health problems potentially linked to vaccines and eligible for compensation) must be supported by scientific evidence. Essentially, this bill puts the vaccine recommendation process on firmer legal ground and makes it more transparent to the public and lawmakers.